Login / Signup

Outcomes of Recurrent Mobile Spine Chordomas.

Joshua M KolzElizabeth P WellingsMatthew T HoudekMichelle J ClarkeMichael J YaszemskiPeter S Rose
Published in: The Journal of the American Academy of Orthopaedic Surgeons (2022)
Recurrent mobile spine chordoma portends a poor prognosis with an overall survival of less than 40% at 5 years. Surgical resection may help prevent new neurologic deficits and tumor metastasis while en bloc excision with negative surgical margins is associated with improved local recurrence-free survival.
Keyphrases
  • free survival
  • poor prognosis
  • long non coding rna
  • traumatic brain injury
  • type diabetes
  • skeletal muscle
  • adipose tissue
  • insulin resistance